NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53
暂无分享,去创建一个
K. Young | Z. Xu-Monette | L. Medeiros | Q. Cai | M. Møller | G. Manyam | E. Hsi | R. Sun | A. Tzankov | C. Ok | M. Tu | Xiaolu Xu